Type Public Website www.spectrumpharm.com | Industry Pharmaceuticals Founded 1987 | |
Traded as NASDAQ: SPPI
S&P 600 Component Key people R. Shrotriya, Chief Executive Officer Stock price SPPI (NASDAQ) US$ 6.57 -0.12 (-1.79%)28 Mar, 4:00 PM GMT-4 - Disclaimer CEO Rajesh C. Shrotriya (Aug 2002–) Headquarters Henderson, Nevada, United States Subsidiaries Allos Therapeutics, Talon Therapeutics Inc |
Obviousness spectrum pharmaceuticals inc vs sandoz inc
Spectrum Pharmaceuticals is an American biopharmaceutical company. The company is located in Irvine, California.
Contents
Spectrum pharmaceuticals ceo we are always looking for
Drugs
Spectrum develops and markets drugs for treatments in oncology.
Approved drugs
In development
A number of drugs are currently investigated in clinical trials.
Spectrum terminated the development of Ozarelix, a luteinizing hormone releasing hormone antagonist for the treatment of benign prostatic hypertrophy in 2010. Other previous drug candidates included ortataxel for the treatment of taxane-refractory tumors, and satraplatin for non-small cell lung cancer.
References
Spectrum Pharmaceuticals Wikipedia(Text) CC BY-SA